Exact Sciences Corp

Most Recent

  • uploads///close up drugs medical medicine
    Company & Industry Overviews

    Wall Street Is Bullish on Nektar Stock despite Stock Price Slump

    Nektar is a development-stage biotechnology company that has a drug pipeline focused on the treatment of cancer, autoimmune diseases, and chronic pain.

    By Sarah Collins
  • Exact Sciences Buys Thrive Earlier Detection

    Exact Sciences to Buy Thrive Earlier Detection, Stock Rises

    Exact Sciences stock rose more than 23 percent on Oct. 27. The company announced that it has agreed to acquire Thrive Earlier Detection.
    By Ambrish Shah
  • why is exact sciences stock going up

    Liquid Biopsy Data Ignites Exact Sciences Stock

    Exact Sciences stock jumped 27 percent on Sept. 24 after the company released favorable cancer blood-test results.
    By Ambrish Shah
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.